<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04407949</url>
  </required_header>
  <id_info>
    <org_study_id>EventLab</org_study_id>
    <nct_id>NCT04407949</nct_id>
  </id_info>
  <brief_title>Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device &quot;prismaLine&quot; With Polysomnography</brief_title>
  <official_title>Untersuchung Der Übereinstimmung Der Ereigniserkennung Von &quot;prismaLine&quot; Geräten Mit Der Polysomnographie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pneumologie Hagen Ambrock eV</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heinen und Löwenstein GmbH &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut für Pneumologie Hagen Ambrock eV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of residual sleep disordered breathing (SDB) under continuous positive airway&#xD;
      pressure (CPAP) therapy with comparison of the automatic detected SDB event indices from CPAP&#xD;
      machines with manual scored polysomnography (PSG).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The evaluation of residual sleep disordered breathing (SDB) in sleep apnea (SA) after&#xD;
      initiation of continuous positive airway pressure (CPAP) therapy is important to verify the&#xD;
      therapeutic success. In clinical practice, the internal records of CPAP devices are utilized&#xD;
      to determine the therapeutic success, during either medical consultations or telemetric&#xD;
      observation.&#xD;
&#xD;
      This study was designed to evaluate the quality of SDB Event Indices (EI), which are recorded&#xD;
      by the CPAP device (Prisma, Löwenstein Medical Technology).&#xD;
&#xD;
      The detected events of a manual scored polysomnography (PSG) in the sleep laboratory will be&#xD;
      compared with the simultaneously recorded events of the CPAP device.&#xD;
&#xD;
      This shall lead to recommendations regarding the situations, and in which degree the event&#xD;
      detection of the CPAP devices may be meaningful to determine the therapeutic success of home&#xD;
      sleep apnea therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 17, 2019</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Every enrolled patient underwent a CPAP - Titration under PSG with predefined pressure steps. Afterwards breathing events are scored manually based on AASM Criteria by a trained study member. The events will be compared with the readout from the CPAP Device.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>apnea- hypopnea- index (AHI)</measure>
    <time_frame>up to 8 hours</time_frame>
    <description>Total number (N) and index (N/h) of sleep disordered breathing events (apnoeas plus hypopneas) from PSG and device log</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hypopnea index relating to oxygen desaturation</measure>
    <time_frame>up to 8 hours</time_frame>
    <description>total number of Hypopneas (N) and Index (N/h) scored under AASM criteria for hypopneas, both rules. 1A: hypopnea events with &gt;= 3% oxygen desaturation and 1B: hypopnea events with &gt;= 4% oxygen desaturation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central and obstructive hypopnea index</measure>
    <time_frame>up to 8 hours</time_frame>
    <description>total number (N) and Index (N/h) of hypopneas scored under AASM criteria for central and obstructive hypopneas.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>event detection</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CPAP Treatment</intervention_name>
    <description>Comparing events from the CPAP device with the events scored in PSG</description>
    <arm_group_label>event detection</arm_group_label>
    <other_name>PrismaLine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  PSG diagnostic not older than 3 month,&#xD;
&#xD;
          -  AHI&gt;15, CPAP indication,&#xD;
&#xD;
          -  age &gt;18,&#xD;
&#xD;
          -  nasal CPAP mask,&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CPAP contraindication,&#xD;
&#xD;
          -  participation in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Nilius, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kliniken Essen-Mitte, Evang. Huyssens-Stiftung/Knappschaft gGmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte, Evang. Huyssens-Stiftung/Knappschaft gGmbH</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut für Pneumologie Hagen Ambrock eV</investigator_affiliation>
    <investigator_full_name>Georg Nilius, PD DR med</investigator_full_name>
    <investigator_title>medical director of pneumologic department</investigator_title>
  </responsible_party>
  <keyword>CPAP</keyword>
  <keyword>Apnea</keyword>
  <keyword>Hypopnea</keyword>
  <keyword>event detection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

